A Distributional Robustness Margin For Pathology Foundation Models
Not on the map. Why?
Abstract (arXiv)
Pathology foundation models encode non-biological variation introduced by tissue preparation, staining and scanning, enabling shortcut learning that undermines generalisation across institutions. The Robustness Index (RI) was proposed to assess whether local representation geometry is dominated by biological or non-biological variation. However, its construction suffers from structural limitations that make cross-model comparison unreliable, calling for a more principled metric. We introduce the Cross-confounder Robustness Margin (CRoMa), a signed, per-sample margin that measures whether samples sharing the same biology but different confounder lie closer than samples sharing the same confounder but different biology. It is defined for every sample, allowing models to be compared on the same cohort and robustness to be analysed as a distribution rather than reduced to a single pooled score. We evaluated CRoMa across 20 tile-level encoders on three benchmarks. Rankings by median CRoMa were highly consistent across benchmarks (Spearman rho ~ 0.90), yet every encoder retained confounder-dominated samples, whose prevalence and severity varied markedly. Similar patterns emerged for four slide-level encoders evaluated on a separate benchmark, extending the analysis beyond tile-level representations. Higher median CRoMa was associated with smaller shortcut-induced performance losses in downstream linear probes, supporting its use as a representation-level indicator of shortcut susceptibility.
Key facts. No citing papers in the map yet (data through 7 Oct 2026). Builds on 20 of its 41 references that are in the map. First posted on arXiv 28 Jul 2026.
Builds on
20 of 41 references.
References · 20
- 2023DINOv2: Learning Robust Visual Features without Supervisioncited by 7,764
- 2021Emerging Properties in Self-Supervised Vision Transformerscited by 6,893
- 2020Shortcut Learning in Deep Neural Networkscited by 1,928
- 2019Self-supervised Visual Feature Learning with Deep Neural Networks: A Surveycited by 656
- 2019Quantifying the effects of data augmentation and stain color normalization in convolutional neural networks for computational pathologycited by 172
- 2024Multimodal Whole Slide Foundation Model for Pathologycited by 156
- 2024Virchow2: Scaling Self-Supervised Mixed Magnification Models in Pathologycited by 144
- 2024PRISM: A Multi-Modal Generative Foundation Model for Slide-Level Histopathologycited by 80
- 2024Phikon-v2, A large and public feature extractor for biomarker predictioncited by 67
- 2024A Clinical Benchmark of Public Self-Supervised Pathology Foundation Modelscited by 64
- 2024A Multimodal Knowledge-enhanced Whole-slide Pathology Foundation Modelcited by 59
- 2024Hibou: A Family of Foundational Vision Transformers for Pathologycited by 52
8 more
- 2024Benchmarking foundation models as feature extractors for weakly-supervised computational pathologycited by 47
- 2025Current Pathology Foundation Models are unrobust to Medical Center Differencescited by 37
- 2025Distilling foundation models for robust and efficient models in digital pathologycited by 33
- 2025Training state-of-the-art pathology foundation models with orders of magnitude less datacited by 19
- 2024Do Histopathological Foundation Models Eliminate Batch Effects? A Comparative Studycited by 17
- 2025The PAR dataset: Prostate biopsy whole slide images from an underrepresented Middle Eastern populationcited by 2
- 2026Deep Learning From Routine Histology Improves Risk Stratification for Biochemical Recurrence in Prostate Cancercited by 2
- 2026MOOZY: A Patient-First Foundation Model for Computational Pathologycited by 2
Built on by
Not cited yet.